1. HBV reactivation in pOBI is influenced by detectable viremia at baseline rather than duration of prophylaxis with lamivudine. Issue 1 (16th February 2017) Authors: Cavallo, F.; Ghione, P.; Battaglini, M.; Botto, B.; Caracciolo, D.; Ferrero, S.; Passera, R.; Vitolo, U.; Boccadoro, M.; Marzano, A. Journal: Digestive and liver disease Issue: Volume 49:Issue 1(2017)Supplement Page Start: e59 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. KMT2D AND TP53 MUTATIONS PREDICT POOR PFS AND OS IN MANTLE CELL LYMPHOMA RECEIVING HIGH‐DOSE THERAPY AND ASCT: THE FONDAZIONE ITALIANA LINFOMI (FIL) MCL0208 PHASE III TRIAL. (June 2017) Authors: Ferrero, S.; Rossi, D.; Bruscaggin, A.; Evangelista, A.; Di Rocco, A.; Spina, V.; Stefoni, V.; Ghione, P.; Barbero, D.; Monitillo, L.; Gomes Da Silva, M.; Santoro, A.; Molinari, A.; Ferreri, A.; Piccin, A.; Cortelazzo, S.; Ladetto, M.; Gaidano, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Retrospective analysis on R‐DHAP/OX and ASCT as salvage treatment for relapsed/refractory high‐risk follicular lymphoma. (June 2017) Authors: Ghione, P.; Cavallo, F.; Visco, C.; Chen, Z.; Nicolosi, M.; Castellino, A.; Tisi, M.C.; Dogliotti, I.; Boccadoro, M.; Leonard, J.P.; Vitolo, U.; Martin, P. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. RISK OF BREAST IMPLANT ASSOCIATED ANAPLASTIC LARGE CELL LYMPHOMA (BIA‐ALCL) IN A COHORT OF 3546 WOMEN PROSPECTIVELY FOLLOWED AFTER RECEIVING TEXTURED BREAST IMPLANTS. (12th June 2019) Authors: Ghione, P.; Cordeiro, P.G.; Ni, A.; Hu, Q.; Ganesan, N.; Galasso, N.; Dogan, A.; Horwitz, S.M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. THE NONCODING RNA GECPAR IS INVOLVED IN WNT SIGNALING AND HAS TUMOR‐SUPPRESSOR ACTIVITY IN DIFFUSE LARGE B CELL LYMPHOMA. (12th June 2019) Authors: Napoli, S.; Cascione, L.; Rinaldi, A.; Sartori, G.; Forcato, M.; Bicciato, S.; Chiappella, A.; Ghione, P.; Elemento, O.; Inghirami, G.; Bertoni, F. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 77 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. TREATMENT AND OUTCOMES OF PATIENTS WITH NK/T‐CELL LYMPHOMA TREATED WITH MODIFIED (m)SMILE AND INTENSITY‐MODULATED RADIOTHERAPY (IMRT), A SINGLE CENTER EXPERIENCE. (12th June 2019) Authors: Ghione, P.; Qi, S.; Imber, B.S.; Venkatraman, S.; Moskowitz, A.; Galasso, N.; Lunning, M.; Straus, D.; Sauter, C.; Dahi, P.; Dogan, A.; Yahalom, J.; Horwitz, S.M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 477 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗